Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in a 100 mL bottle, Rx only, Manuf...

FDA Recall #D-0440-2017 — Class II — December 21, 2016

Recall #D-0440-2017 Date: December 21, 2016 Classification: Class II Status: Terminated

Product Description

Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in a 100 mL bottle, Rx only, Manufactured for: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-4150-73

Reason for Recall

Subpotency: due to a low, out of specification test result for assay during stability testing.

Recalling Firm

Teva Pharmaceuticals USA — North Wales, PA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

133,601 bottles

Distribution

United States and Puerto Rico

Code Information

Lot # 35432507A, 35434914A, 35435798A, 35437490A, Exp 9/19

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated